325 related articles for article (PubMed ID: 31634150)
1. Beneficial effects of PGC-1α in the substantia nigra of a mouse model of MPTP-induced dopaminergic neurotoxicity.
Wang Y; Chen C; Huang W; Huang M; Wang J; Chen X; Ye Q
Aging (Albany NY); 2019 Oct; 11(20):8937-8950. PubMed ID: 31634150
[TBL] [Abstract][Full Text] [Related]
2. Pgc-1α overexpression downregulates Pitx3 and increases susceptibility to MPTP toxicity associated with decreased Bdnf.
Clark J; Silvaggi JM; Kiselak T; Zheng K; Clore EL; Dai Y; Bass CE; Simon DK
PLoS One; 2012; 7(11):e48925. PubMed ID: 23145024
[TBL] [Abstract][Full Text] [Related]
3. Sphingosine kinase 2 and sphingosine-1-phosphate promotes mitochondrial function in dopaminergic neurons of mouse model of Parkinson's disease and in MPP+ -treated MN9D cells in vitro.
Sivasubramanian M; Kanagaraj N; Dheen ST; Tay SS
Neuroscience; 2015 Apr; 290():636-48. PubMed ID: 25637806
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of PGC-1α Influences Mitochondrial Signal Transduction of Dopaminergic Neurons.
Ye Q; Huang W; Li D; Si E; Wang J; Wang Y; Chen C; Chen X
Mol Neurobiol; 2016 Aug; 53(6):3756-3770. PubMed ID: 26141122
[TBL] [Abstract][Full Text] [Related]
5. Teaghrelin protected dopaminergic neurons in MPTP-induced Parkinson's disease animal model by promoting PINK1/Parkin-mediated mitophagy and AMPK/SIRT1/PGC1-α-mediated mitochondrial biogenesis.
Jhuo CF; Chen CJ; Tzen JTC; Chen WY
Environ Toxicol; 2024 Jul; 39(7):4022-4034. PubMed ID: 38622810
[TBL] [Abstract][Full Text] [Related]
6. Liraglutide Regulates Mitochondrial Quality Control System Through PGC-1α in a Mouse Model of Parkinson's Disease.
Wu P; Dong Y; Chen J; Guan T; Cao B; Zhang Y; Qi Y; Guan Z; Wang Y
Neurotox Res; 2022 Feb; 40(1):286-297. PubMed ID: 35043376
[TBL] [Abstract][Full Text] [Related]
7. Transgenic expression and activation of PGC-1α protect dopaminergic neurons in the MPTP mouse model of Parkinson's disease.
Mudò G; Mäkelä J; Di Liberto V; Tselykh TV; Olivieri M; Piepponen P; Eriksson O; Mälkiä A; Bonomo A; Kairisalo M; Aguirre JA; Korhonen L; Belluardo N; Lindholm D
Cell Mol Life Sci; 2012 Apr; 69(7):1153-65. PubMed ID: 21984601
[TBL] [Abstract][Full Text] [Related]
8. Mitochondrial Effects of PGC-1alpha Silencing in MPP
Ye Q; Chen C; Si E; Cai Y; Wang J; Huang W; Li D; Wang Y; Chen X
Front Mol Neurosci; 2017; 10():164. PubMed ID: 28611589
[TBL] [Abstract][Full Text] [Related]
9. PGC-1α-siRNA suppresses inflammation in substantia nigra of PD mice by inhibiting microglia.
Guan X; Wu P; Cao B; Liu X; Chen X; Zhang W; Zhang Y; Guan Z; Wang Y
Int J Neurosci; 2023 Mar; 133(3):269-277. PubMed ID: 33784949
[No Abstract] [Full Text] [Related]
10. Alpha-Lipoic Acid Attenuates MPTP/MPP
Zhang J; Gao Y; Zhang L; Zhang C; Zhao Y; Zhang Y; Li S; Chang C; Zhang X; Yang G
Neurotox Res; 2022 Apr; 40(2):410-419. PubMed ID: 35146598
[TBL] [Abstract][Full Text] [Related]
11. PGC-1α/ERRα-Sirt3 Pathway Regulates DAergic Neuronal Death by Directly Deacetylating SOD2 and ATP Synthase β.
Zhang X; Ren X; Zhang Q; Li Z; Ma S; Bao J; Li Z; Bai X; Zheng L; Zhang Z; Shang S; Zhang C; Wang C; Cao L; Wang Q; Ji J
Antioxid Redox Signal; 2016 Feb; 24(6):312-28. PubMed ID: 26421366
[TBL] [Abstract][Full Text] [Related]
12. EGb761 protects against nigrostriatal dopaminergic neurotoxicity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice: role of oxidative stress.
Rojas P; Serrano-García N; Mares-Sámano JJ; Medina-Campos ON; Pedraza-Chaverri J; Ogren SO
Eur J Neurosci; 2008 Jul; 28(1):41-50. PubMed ID: 18662333
[TBL] [Abstract][Full Text] [Related]
13. Activation of the ATF2/CREB-PGC-1α pathway by metformin leads to dopaminergic neuroprotection.
Kang H; Khang R; Ham S; Jeong GR; Kim H; Jo M; Lee BD; Lee YI; Jo A; Park C; Kim H; Seo J; Paek SH; Lee YS; Choi JY; Lee Y; Shin JH
Oncotarget; 2017 Jul; 8(30):48603-48618. PubMed ID: 28611284
[TBL] [Abstract][Full Text] [Related]
14. Roflupram exerts neuroprotection via activation of CREB/PGC-1α signalling in experimental models of Parkinson's disease.
Zhong J; Dong W; Qin Y; Xie J; Xiao J; Xu J; Wang H
Br J Pharmacol; 2020 May; 177(10):2333-2350. PubMed ID: 31972868
[TBL] [Abstract][Full Text] [Related]
15. Effect of MPTP on mRNA expression of PGC-1α in mouse brain.
Torok R; Salamon A; Sumegi E; Zadori D; Veres G; Molnar MF; Vecsei L; Klivenyi P
Brain Res; 2017 Apr; 1660():20-26. PubMed ID: 28161458
[TBL] [Abstract][Full Text] [Related]
16. Hyperbaric Oxygen Therapy Improves Parkinson's Disease by Promoting Mitochondrial Biogenesis via the SIRT-1/PGC-1α Pathway.
Hsu HT; Yang YL; Chang WH; Fang WY; Huang SH; Chou SH; Lo YC
Biomolecules; 2022 Apr; 12(5):. PubMed ID: 35625589
[TBL] [Abstract][Full Text] [Related]
17. The novel tetramethylpyrazine bis-nitrone (TN-2) protects against MPTP/MPP+-induced neurotoxicity via inhibition of mitochondrial-dependent apoptosis.
Xu D; Duan H; Zhang Z; Cui W; Wang L; Sun Y; Lang M; Hoi PM; Han Y; Wang Y; Lee SM
J Neuroimmune Pharmacol; 2014 Mar; 9(2):245-58. PubMed ID: 24233519
[TBL] [Abstract][Full Text] [Related]
18. Transgenic mice with increased Cu/Zn-superoxide dismutase activity are resistant to N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity.
Przedborski S; Kostic V; Jackson-Lewis V; Naini AB; Simonetti S; Fahn S; Carlson E; Epstein CJ; Cadet JL
J Neurosci; 1992 May; 12(5):1658-67. PubMed ID: 1578260
[TBL] [Abstract][Full Text] [Related]
19. 7,8-dihydroxyflavone Ameliorates Motor Deficits Via Suppressing α-synuclein Expression and Oxidative Stress in the MPTP-induced Mouse Model of Parkinson's Disease.
Li XH; Dai CF; Chen L; Zhou WT; Han HL; Dong ZF
CNS Neurosci Ther; 2016 Jul; 22(7):617-24. PubMed ID: 27079181
[TBL] [Abstract][Full Text] [Related]
20. Sustained expression of PGC-1α in the rat nigrostriatal system selectively impairs dopaminergic function.
Ciron C; Lengacher S; Dusonchet J; Aebischer P; Schneider BL
Hum Mol Genet; 2012 Apr; 21(8):1861-76. PubMed ID: 22246294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
